Inmune Bio Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: INMB
TL;DR
INMB filed an 8-K, likely containing updates. Check for details.
AI Summary
On June 26, 2025, Inmune Bio, Inc. filed an 8-K report. The filing indicates "Other Events" and "Financial Statements and Exhibits" as key items. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Inmune Bio, Inc. has submitted a current report to the SEC, which may contain updates on significant company events or financial information.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing notification and does not contain information that inherently poses a high risk.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432 (address) — Principal Executive Offices
FAQ
What specific events are reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items, but the specific details of these events are not provided in the excerpt.
When was this 8-K report filed?
The report was filed on June 26, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Inmune Bio Inc.
In which state is Inmune Bio, Inc. incorporated?
Inmune Bio, Inc. is incorporated in Nevada.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Inmune Bio, Inc. (INMB).